Genetic variation in neuronal nitric oxide synthase (nNOS) gene and susceptibility to cerebral malaria in Indian adults

Infection, Genetics and Evolution

Volumn 9, Issue 5, 2009, Pages 908-911

  Dhangadamajhi, Gunanidhi ^a   Mohapatra, Biranchi N ^b   Kar, Shantanu K ^a   Ranjit, Manoranjan ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

^b SCB MEDICAL COLLEGE   (India)

Author keywords

Cerebral malaria; nNOS; Plasmodium falciparum; Polymorphism

Indexed keywords

ADENINE; CYTOSINE; GUANINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; THYMINE;

ADULT; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANIMALS; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; NITRIC OXIDE SYNTHASE TYPE I; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

PLASMODIUM FALCIPARUM;

EID: 67651119855     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.06.010     Document Type: Article

References (31)

1. Al-Yaman F.M., Mokela D., Genton B., Rockett K.A., Alpers M.P., and Clark I.A. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 270-273
2. Anstey N.M., Granger D.L., Hassanali M.Y., Mwaikambo E.D., Duffy P.E., and Weinberg J.B. Nitric oxide, malaria, and anemia: inverse relationship between nitric oxide production and hemoglobin concentration in asymptomatic, malaria-exposed children. Am. J. Trop. Med. Hyg. 61 (1999) 249-252
3. Anstey N.M., Weinberg J.B., Hassanali M.Y., Mwaikambo E.D., Manyenga D., Misukonis M.A., Arnelle D.R., Hollis D., McDonald M.I., and Granger D.L. Nitric oxide in Tanzanian children with malaria; inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184 (1996) 557-567
4. Balmer P., Phillips H.M., Maestre A.E., McMonagle F.A., and Phillips R.S. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro. Parasite Immunol. 22 (2000) 97-106
5. Bredt D.S., and Snyder S.H. Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 13 (1994) 301-313
6. Burgner D., Usen S., Rockett K., Jallow M., Ackerman H., Cervino A., Pinder M., and Kwiatkowski D.P. Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria. Hum. Genet. 112 (2003) 379-386
7. Chiwakata C.B., Hemmer C.J., and Dietrich M. High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. Infect. Immun. 68 (2000) 394-399
8. Clark I.A., and Cowden W.B. The pathophysiology of falciparum malaria. Pharmacol. Ther. 99 (2003) 221-260
9. Dhangadamajhi G., Mohapatra B.N., Kar S.K., and Ranjit M.R. The CCTTT pentanucleotide microsatellite in iNOS promoter influences the clinical outcome in P. falciparum infection. Parasitol. Res. January 20 (2009) (Epub ahead of print)
10. Gramaglia, I., Sobolewski, P., Meays, D., Contreras, R., Nolan, J.P., Frangos, J.A., Intaglietta, M., van der Heyde, H.C., 2006. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. 12, 1417-1422.
11. Greenwood B., and Marsh K.S.R. Why do some African children develop severe malaria?. Parasitol. Today 7 (1991) 277
12. Kishimoto J., Spurr N., Liao M., Lizhi L., Emson P., and Xu W. Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics 14 (1992) 802-804
13. Kremsner P.G., Winklerls S., Wildlingls E., Prada J., Bienzle U., Graninger W., and Niissler A.K. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 44-47
14. Li C., Hu Z., Liu Z., Wang L., Gershenwald J.E., Lee J.E., Prieto V.G., Duvic M., Grimm E.A., and Wei Q. Polymorphisms of the neural and inducible nitric oxide synthase genes and the risk of cutaneous melanoma. A case-control study. Cancer 109 (2007) 1570-1578
15. Maneerat Y., Viriyavejakul P., Punpoowong B., Jones M., Wilairantana P., Pongponratn E., Turner G., and Udomsangpetch R. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology 37 (2000) 269-277
16. Mazier D., Nitcheu J., and Idrissa-Boubou M. Cerebral malaria and immunogenetics. Parasite Immunol. 22 (2000) 613-623
17. Morahan G., Boutlis C.S., Huang D., Pain A., Saunders J.R., Hobbs M.R., Granger D.L., Weinberg J.B., Peshu N., Mwaikambo E.D., Marsh K., Roberts D.J., and Anstey N.M. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun. 3 (2002) 414-418
18. Nahrevanian H. Immune effector mechanisms of the Nitric oxide pathway in malaria: cytotoxicity versus cytoprotection. Braz. J. Infect. Dis. 10 (2006) 283-292
19. Perkins D.J., Kremsner P.G., Schmid D., Misukonis M.A., Kelly M.A., and Weinberg J.B. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria. Infect. Immun. 67 (1999) 4977-4981
20. Ranjit M.R. The epidemiology of malaria in Orissa. ICMR Bull. 36 (2006) 29-38
21. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual. 3rd ed. vol. 1 (2001), Cold Spring Harbor Laboratory Press, New York pp. 6.4-6.11
22. Saur D., Seidler B., Paehge H., Schusdziarra V., and Allescher H.D. Complex regulation of human neuronal nitric oxide synthase exon 1c gene transcription. J. Biol. Chem. 277 (2002) 25798-25814
23. Saur D., Vanderwinden J.M., Seidler B., Schmid R.M., De Laet M.H., and Allescher H.D. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1662-1667
24. Serirom S., Raharjo W.H., Chotivanich K., Loareesuwan S., Kubes P., and Ho M. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am. J. Pathol. 162 (2003) 1651-1660
25. Sobolewski P., Gramaglia I., Frangos J., Intaglietta M., and Van der Heyde H.C. Nitric oxide bioavailability in malaria. Trends Parasitol. 21 (2005) 415-422
26. Van der Heyde H.C., Nolan J., Combes V., Gramaglia I., and Grau G.E. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22 (2006) 503-508
27. Wang Y., Newton D.C., Robb G.B., Kau C.L., Miller T.L., Cheung A.H., Hall A.V., VanDamme S., Wilcox J.N., and Marsden P.A. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 12150-12155
28. Severe falciparum malaria, World Health Organization, Communicable Diseases Cluster. Trans. R. Soc. Trop. Med. Hyg. 94 (2000) S1-S90
29. WHO, 2008. World Malaria Report, Summary and Key Points. Available from http://www.who.int/malaria/wmr2008/MAL2008-SumKey-EN-pdf.
30. Xie K., and Huang S. Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency. Free Radic. Biol. Med. 34 (2003) 969-986
31. Yu Y.W., Chen T.J., Wang Y.C., Liou Y.J., Hong C.J., and Tsai S.J. Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology 47 (2003) 137-140